Larvol Cliniclarvol.hashnode.devยทSep 20, 2024A Phase I Study of a Novel Anti-PD-1 Monoclonal AntibodyPF-06801591 is a humanized IgG4 monoclonal antibody that binds to programmed cell death (PD-1) receptor, blocking its interaction with PD-1 ligands. In a phase I study (NCT02573259; dose-escalation) of 40 patients (pts) with multiple solid tumor type...TumorAdd a thoughtful commentNo comments yetBe the first to start the conversation.
